Vergent Bioscience, Inc.
Minneapolis, MN · Founded 2013 · CIK 0001741495 · Biotech · Private
VGT-309, a molecular imaging agent that binds to cathepsins in tumor tissue and fluoresces under near-infrared light for intraoperative tumor visualization
vergentbio.com →- Grants
- $2.9M
- 2 awards
- Sector median: 1
- Raised
- $54M
- 5 Form D · Oct 2025
- 12 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 0 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $8,680,613 | |
| Private capital raised | Form D · SEC | $1,163,814 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent | $1,998,535 | |
| Private capital raised | Form D · SEC | $21,542,628 | |
| Federal grant | Department of Health and Human Services · Phase II · Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent | $874,253 | |
| Private capital raised | Form D · SEC | $3,750,000 | |
| Private capital raised | Form D · SEC | $18,673,277 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1132 | MS Biotech Holdings, Inc. | — | $59M |
| 1133 | PROLACTA BIOSCIENCE INC | — | $65M |
| 1134 | CalciMedica Subsidiary, Inc. | — | $67M |
| 1135 | Vergent Bioscience, Inc. | — | $54M |
| 1136 | REGENOSINE INC | — | — |
| 1137 | Synata Bio, Inc. | — | $52M |
| 1138 | SYNSORYBIO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Samuel BanksDirector
- Samuel Dean BanksDirector
- Ryan EgelandDirector
- Bobby HelmedagDirector
- Jeff JulkowskiDirector
- Jeffrey JulkowskiDirector · Promoter
- Douglas KohrsDirector
- John SantiniDirector · Executive Officer
- John Santini, Jr.Director · Executive Officer
- Margo ShoupDirector
- Anita WatkinsDirector
- Anita WilsonDirector
- Raymond WongDirector
- Jeffrey YureckoExecutive Officer
Patents
- Methods for Localization of Cancerous Tissue Using Fluorescent Molecular Imaging Agent for Diagnosis or Treatmentapplication
- Methods for Localization of Cancerous Tissue Using Fluorescent Molecular Imaging Agent for Diagnosis or Treatmentapplication
- Methods For Localization Of Cancerous Tissue Using Fluorescent Molecular Imaging Agent For Diagnosis Or Treatmentapplication
- Methods for Localization, Biopsy, Resection, or Destruction of Nodules and Tumors Using Fluorescent Molecular Imaging Agentapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.